Chirag K. Patel Receives Stock Award at Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Mar 03, 2026
This filing has been amended.
View the latest version
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Chirag K. Patel CIK 0001738701 |
Director
CEO
|
Chirag K. Patel at Amneal Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amneal Pharmaceuticals Inc
| 2026-08-12 | Award | — | View |
| 2026-03-05 | Exercise | — | View |
| 2025-03-06 | Exercise | — | View |
| 2024-03-06 | Award | — | View |
| 2023-11-08 | Gift/Other | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1F2F2 | 2026-03-02 | A - Award/Grant | 190,632 A | $0.00 | 190,632 Class A Common Stock | Direct | ||
| Performance-Based Restricted Stock UnitsF3F4F4 | 2026-03-02 | A - Award/Grant | 354,031 A | $0.00 | 354,031 Class A Common Stock | Direct |
Footnotes (4)
- F1
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Show more
- F2
- The restricted stock units vest in four equal annual installments beginning on March 2, 2027. Show more
- F3
- Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Show more
- F4
- Represents a performance-based restricted stock unit grant of 354,031 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period. Show more
Related filings at Amneal Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
312
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $460M
- Tpg Gp A, Llc $213M
- Vanguard Portfolio Management Llc $210M
5%+ Holders · 13D/G
6 filers
-
Chintu Patel 9.4%
-
Chirag Patel 8.4%
-
Tushar Patel 17.6%
-
Black Rock, Inc. 7.6%
-
Patel Dipan 5.4%
Other insiders at Amneal Pharmaceuticals Inc
GET /v1/forms/4/0001628280-26-013893
API docs
View Original SEC Filing